Status:
COMPLETED
A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to demonstrate whether subjects respond similarly to the Onset of Effect Questionnaire (OEQ) using a 1 week recall period versus a 1 day recall period.
Eligibility Criteria
Inclusion
- Male or Female, \> 18 years of age
- Mild to moderate asthma requiring treatment with an inhaled corticosteroid
- Diagnosis of asthma for at least 6 months
Exclusion
- Subjects requiring treatment with systemic corticosteroids (e.g., oral, parenteral, ocular)
- Subjects with severe asthma, as judged by investigator
- Any significant disease or disorder that may jeopardize a subject's safety
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT00449527
Start Date
March 1 2007
End Date
August 1 2007
Last Update
January 24 2011
Active Locations (44)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Tuscumbia, Alabama, United States
2
Research Site
Fort Smith, Arkansas, United States
3
Research Site
Long Beach, California, United States
4
Research Site
Orange, California, United States